US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.150
  • +0.150+2.50%
Close May 2 16:00 ET
  • 6.150
  • 0.0000.00%
Post 19:15 ET
516.13MMarket Cap-1971P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
505.77%11.76M
408.30%5.14M
235.52%3.12M
2.09M
1.4M
1.94M
1.01M
929K
0
0
Operating revenue
505.77%11.76M
408.30%5.14M
235.52%3.12M
--2.09M
--1.4M
--1.94M
--1.01M
--929K
--0
--0
Cost of revenue
Gross profit
Operating expense
40.12%234.88M
21.28%59.09M
23.80%55.45M
43.81%60.68M
86.88%59.66M
92.53%167.63M
49.73%48.72M
90.58%44.79M
148.71%42.19M
127.05%31.93M
Selling and administrative expenses
33.05%49.94M
7.37%12.28M
21.83%11.69M
47.97%13.42M
68.84%12.55M
98.96%37.53M
73.28%11.44M
59.68%9.59M
156.06%9.07M
173.75%7.44M
-General and administrative expense
33.05%49.94M
7.37%12.28M
21.83%11.69M
47.97%13.42M
68.84%12.55M
98.96%37.53M
73.28%11.44M
59.68%9.59M
156.06%9.07M
173.75%7.44M
Research and development costs
42.16%184.95M
25.55%46.81M
24.34%43.77M
42.67%47.26M
92.36%47.11M
90.75%130.1M
43.74%37.28M
101.18%35.2M
146.78%33.13M
115.87%24.49M
Operating profit
-34.67%-223.12M
-13.07%-53.95M
-19.32%-52.33M
-38.85%-58.58M
-82.49%-58.26M
-90.30%-165.69M
-46.62%-47.71M
-86.62%-43.86M
-148.71%-42.19M
-127.05%-31.93M
Net non-operating interest income expense
237.35%23.17M
40.88%6.34M
195.60%5.84M
1,665.58%5.44M
6,663.41%5.55M
4,735.92%6.87M
6,932.81%4.5M
3,628.30%1.98M
6,060.00%308K
310.00%82K
Non-operating interest income
----
----
195.60%5.84M
1,665.58%5.44M
6,663.41%5.55M
----
----
3,628.30%1.98M
6,060.00%308K
--82K
Total other finance cost
-237.35%-23.17M
----
----
----
----
-4,735.92%-6.87M
----
----
----
----
Other net income (expense)
-88.90%165K
-132.75%-713K
124.26%802K
-170.58%-662K
-55.99%738K
104.45%1.49M
91.13%2.18M
-572.29%-3.31M
102.61%938K
115.55%1.68M
Other non- operating income (expenses)
-88.90%165K
-132.75%-713K
124.26%802K
-170.58%-662K
-55.99%738K
104.45%1.49M
91.13%2.18M
-572.29%-3.31M
102.61%938K
115.55%1.68M
Income before tax
-26.99%-199.79M
-17.76%-48.32M
-1.11%-45.69M
-31.41%-53.81M
-72.30%-51.98M
-30.77%-157.33M
-30.94%-41.03M
-98.65%-45.19M
22.69%-40.95M
-127.44%-30.17M
Income tax
418.87%275K
-39.62%32K
67K
176K
53K
53K
0
0
Net income
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
22.69%-40.95M
-127.44%-30.17M
Net income continuous Operations
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
22.69%-40.95M
-127.44%-30.17M
Minority interest income
Net income attributable to the parent company
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
22.69%-40.95M
-127.44%-30.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
22.69%-40.95M
-127.44%-30.17M
Basic earnings per share
-7.22%-3.12
-2.99%-0.69
8.86%-0.72
-3.57%-0.87
-35.48%-0.84
35.04%-2.91
-3.08%-0.67
-68.09%-0.79
23.96%-0.84
-104.85%-0.62
Diluted earnings per share
-7.22%-3.12
-2.99%-0.69
8.86%-0.72
-3.57%-0.87
-35.48%-0.84
35.04%-2.91
-3.08%-0.67
-68.09%-0.79
23.96%-0.84
-104.85%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 505.77%11.76M408.30%5.14M235.52%3.12M2.09M1.4M1.94M1.01M929K00
Operating revenue 505.77%11.76M408.30%5.14M235.52%3.12M--2.09M--1.4M--1.94M--1.01M--929K--0--0
Cost of revenue
Gross profit
Operating expense 40.12%234.88M21.28%59.09M23.80%55.45M43.81%60.68M86.88%59.66M92.53%167.63M49.73%48.72M90.58%44.79M148.71%42.19M127.05%31.93M
Selling and administrative expenses 33.05%49.94M7.37%12.28M21.83%11.69M47.97%13.42M68.84%12.55M98.96%37.53M73.28%11.44M59.68%9.59M156.06%9.07M173.75%7.44M
-General and administrative expense 33.05%49.94M7.37%12.28M21.83%11.69M47.97%13.42M68.84%12.55M98.96%37.53M73.28%11.44M59.68%9.59M156.06%9.07M173.75%7.44M
Research and development costs 42.16%184.95M25.55%46.81M24.34%43.77M42.67%47.26M92.36%47.11M90.75%130.1M43.74%37.28M101.18%35.2M146.78%33.13M115.87%24.49M
Operating profit -34.67%-223.12M-13.07%-53.95M-19.32%-52.33M-38.85%-58.58M-82.49%-58.26M-90.30%-165.69M-46.62%-47.71M-86.62%-43.86M-148.71%-42.19M-127.05%-31.93M
Net non-operating interest income expense 237.35%23.17M40.88%6.34M195.60%5.84M1,665.58%5.44M6,663.41%5.55M4,735.92%6.87M6,932.81%4.5M3,628.30%1.98M6,060.00%308K310.00%82K
Non-operating interest income --------195.60%5.84M1,665.58%5.44M6,663.41%5.55M--------3,628.30%1.98M6,060.00%308K--82K
Total other finance cost -237.35%-23.17M-----------------4,735.92%-6.87M----------------
Other net income (expense) -88.90%165K-132.75%-713K124.26%802K-170.58%-662K-55.99%738K104.45%1.49M91.13%2.18M-572.29%-3.31M102.61%938K115.55%1.68M
Other non- operating income (expenses) -88.90%165K-132.75%-713K124.26%802K-170.58%-662K-55.99%738K104.45%1.49M91.13%2.18M-572.29%-3.31M102.61%938K115.55%1.68M
Income before tax -26.99%-199.79M-17.76%-48.32M-1.11%-45.69M-31.41%-53.81M-72.30%-51.98M-30.77%-157.33M-30.94%-41.03M-98.65%-45.19M22.69%-40.95M-127.44%-30.17M
Income tax 418.87%275K-39.62%32K67K176K53K53K00
Net income -27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M22.69%-40.95M-127.44%-30.17M
Net income continuous Operations -27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M22.69%-40.95M-127.44%-30.17M
Minority interest income
Net income attributable to the parent company -27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M22.69%-40.95M-127.44%-30.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M22.69%-40.95M-127.44%-30.17M
Basic earnings per share -7.22%-3.12-2.99%-0.698.86%-0.72-3.57%-0.87-35.48%-0.8435.04%-2.91-3.08%-0.67-68.09%-0.7923.96%-0.84-104.85%-0.62
Diluted earnings per share -7.22%-3.12-2.99%-0.698.86%-0.72-3.57%-0.87-35.48%-0.8435.04%-2.91-3.08%-0.67-68.09%-0.7923.96%-0.84-104.85%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg